Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.

"Declarations Ethics approval and consent to participateThe trial was approved by the fudan university shanghai cancer center ethics committee (2108241-22). The study is registered in ClinicalTrails.gov (NCT04320979). Written informed consent will be obtained from all participants included in the study prior to randomization. Consent for publicationNot Applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by the WU JIEPING MEDICAL FOUNDATION (320.6750.2022-19-39). The funding source has no role in study design, data collection, analysis, interpretation, the writing of the manuscript, or the decision to submit the current study."

"Trial registration ClinicalTrials.gov Identifier: NCT05059379. Registered 28 September 2021, https://www.clinicaltrials.gov/ct2/show/NCT05059379."